Pfizer Shot Ready for Regulators; Berlin Protests: Virus Update

Pfizer Inc. said a final analysis of clinical-trial data showed its vaccine was 95% effective, paving the way for the company to apply for the first U.S. regulatory authorization for a coronavirus shot within days.